Pharmacovigilance at Glance :- Safety Monitoring | PharmaTutor
Evaluation of safety and immunogenicity of receptor-binding domain-based COVID-19 vaccine (Corbevax) to select the optimum formulation in open-label, multicentre, and randomised phase-1/2 and phase-2 clinical trials - eBioMedicine
Data and Safety Monitoring in Clinical Trials Harvey Murff, M.D., M.P.H. GCRC, Vanderbilt University Medical Center. - ppt download
Importance and role of independent data monitoring committees (IDMCs) in oncology clinical trials | BMJ Open
Safety Workshop: Part I Clinical Trial Safety and Safety Monitoring - ppt download
Risk-proportionate clinical trial monitoring: an example approach from a non-commercial trials unit | Trials | Full Text
Safety monitoring during Clinical Trial - YouTube
Safety Monitoring and Adverse Event Reporting in Clinical Trials: Regulatory Requirements and Best Practices
Decision Tree for Data and Safety Monitoring Plan | NIH: National Institute of Allergy and Infectious Diseases